http://orcid.org/0000-0003-2682-537X

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping

Journal Article

Barbier, Michaela Carla; Fengler, Alicia; Pardo, Esther; Bhadhuri, Arjun; Meier, Niklaus; Gautschi, Oliver (2023). Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland. PharmacoEconomics, 41(12), pp. 1641-1655. Springer 10.1007/s40273-023-01305-3

Provide Feedback